Transasia Bio-Medicals Ltd.’s Post

Major Investments in the #EPCatheterAblation Market: Johnson & Johnson continues to strengthen its market presence through its subsidiary, Biosense Webster, focusing on expanding its product line with new ablation catheters, contributing to over 30% of the market revenue. Abbott has recently announced a $250 million investment into enhancing its next-generation ablation catheters, designed to improve precision and patient outcomes. Medtronic is expanding its electrophysiology portfolio with a strategic investment of $500 million in catheter ablation technologies. This initiative aims to address rising demand in Asia-Pacific, where market growth is estimated at 14.5% annually. Boston Scientific is gearing up for the release of its latest radiofrequency ablation catheter with an investment of $300 million in R&D, focused on increasing accuracy and reducing procedure time. Biotronik recently invested €100 million in its ablation catheter product line to meet the increasing demand for innovative solutions across Europe and North America. Japan Lifeline has committed $80 million to expand its production facilities and improve catheter manufacturing processes, capitalizing on the growing Asian market. OSYPKA continues to innovate by allocating $60 million toward product development, focusing on advanced ablation technologies aimed at improving procedural efficiency. MicroPort EP MedTech has secured $120 million in funding for expanding its EP catheter portfolio and is looking to strengthen its presence in emerging markets like China and India. CardioFocus recently closed a $150 million funding round aimed at enhancing its laser ablation catheter technology, positioning itself as a leader in precision ablation treatments. Johnson & Johnson Abbott Medtronic Boston Scientific BIOTRONIK Japan Lifeline Co., Ltd. OSYPKA AG MicroPort CardioFocus Read Report @ https://lnkd.in/gfXE5N2S #HealthcareInnovation #MedicalDevices #HealthTech #Cardiology #EPMarket #HeartHealth #MedTech #PatientCare #CardiacElectrophysiology #AblationTherapy #ArrhythmiaCare #Electrophysiology #GlobalHealthcare #MedicalResearch #HealthcareTech #LifeSciences #MedicalInvestments #DigitalHealth #ClinicalResearch #EPCatheterAblation #EPMarketGrowth #CardiologyResearch #MedTechInsights #AblationMarket #HealthcareR&D #AblationCatheters #ArrhythmiaTreatment #CardioCare #MedTechInvestments #ElectrophysiologyMarket #AblationInnovation #HealthcareGrowth #CatheterTechnologies #HeartRhythmDisorders #AblationDevices #CatheterAblationResearch #MedicalTechnology #MarketForecast #HealthcareAnalytics

𝗕𝗶𝗼𝗽𝘀𝘆 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟮. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report offers an overview of the Biopsy Devices industry chain's development, evaluating the market status of Hospitals (Stereotactic X-Ray Guided Biopsy, Ultrasound Guided Biopsy) and Diagnostic Centres (Stereotactic X-Ray Guided Biopsy, Ultrasound Guided Biopsy), along with key enterprises across developed and developing markets. It analyzes cutting-edge technology, patents, hot applications, and market trends within the Biopsy Devices sector. Regionally, the report examines Biopsy Devices markets in key regions, with North America and Europe witnessing steady growth propelled by government initiatives and rising consumer awareness. Meanwhile, Asia-Pacific, particularly China, leads the global Biopsy Devices market, fueled by robust domestic demand, supportive policies, and a strong manufacturing base. Key features of the report include a comprehensive understanding of the Biopsy Devices market, providing holistic insights into the industry and detailed analyses of market dynamics, trends, challenges, and opportunities within the sector. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗚𝗹𝗼𝗯𝗮𝗹 𝗦𝗰𝗼𝗽𝗲 𝗮𝗻𝗱 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗕𝗶𝗼𝗽𝘀𝘆 𝗗𝗲𝘃𝗶𝗰𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁.𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dvzEs9pF *𝗕𝘆 𝗧𝘆𝗽𝗲: Stereotactic X-Ray Guided Biopsy,  Ultrasound Guided Biopsy,  MRI Guided Biopsy *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospitals,  Diagnostic Centres,  Research Institutes,  Other *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: BD Medical,  Argon Medical,  B. Braun Melsungen,  Boston Scientific,  C. R. Bard,  Hologic,  Cook Medical,  INRAD,  Devicor Medical Products,  Planmed Oy,  Stryker,  Galini SRL #biopsydevices #medicaldevices #cancerdiagnosis #healthcaretechnology #oncology #tissuediagnosis #biomedicalengineering #medicalresearch #biopsysurgery #tissueextraction #diagnosticimaging #surgicalinstruments #medicalinstrumentation #pathology #tissuebiopsy #medicalinnovation #healthcareindustry #biopsyprocedure #patientcare #medicaltechnology #healthcaremarket

𝗚𝗹𝗼𝗯𝗮𝗹 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐆𝐫𝐚𝐟𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟐) The global vascular grafts market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032. The report provides a detailed analysis of competitors and regions, offering insights into the industry's landscape. It breaks down various segments, giving a clear view of how each part contributes to the overall market. By examining these segments, the report helps identify trends and patterns that may affect future strategies and planning. 𝐆𝐫𝐚𝐛 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅: https://lnkd.in/gY3RP-JT 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐲𝐧𝐚𝐦𝐢𝐜𝐬: ● 𝐑𝐢𝐬𝐢𝐧𝐠 𝐏𝐫𝐞𝐯𝐚𝐥𝐞𝐧𝐜𝐞 𝐨𝐟 𝐂𝐚𝐫𝐝𝐢𝐨𝐯𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐃𝐢𝐬𝐞𝐚𝐬𝐞𝐬: The increasing incidence of coronary artery disease and peripheral artery disease has driven a surge in demand for vascular grafts. As these conditions require surgical intervention, vascular grafts play a crucial role in bypass procedures, fueling market growth. ● 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐀𝐝𝐯𝐚𝐧𝐜𝐞𝐦𝐞𝐧𝐭𝐬 𝐢𝐧 𝐆𝐫𝐚𝐟𝐭 𝐌𝐚𝐭𝐞𝐫𝐢𝐚𝐥𝐬: The development of innovative vascular graft materials, including biocompatible and biodegradable options, has expanded the range of available products. These advancements offer improved patient outcomes and reduce the risk of complications, contributing to market growth. ● 𝐀𝐠𝐢𝐧𝐠 𝐏𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐚𝐧𝐝 𝐈𝐧𝐜𝐫𝐞𝐚𝐬𝐞𝐝 𝐋𝐢𝐟𝐞𝐬𝐩𝐚𝐧: The global aging population, coupled with advancements in healthcare, has led to an increase in the lifespan of individuals. This has resulted in a higher prevalence of age-related cardiovascular diseases, further driving demand for vascular grafts. 𝐓𝐨𝐩 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐒𝐡𝐚𝐩𝐢𝐧𝐠 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐕𝐚𝐬𝐜𝐮𝐥𝐚𝐫 𝐆𝐫𝐚𝐟𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲: Abbott Laboratories B. Braun SE (B. Braun Holding GmbH & Co. KG) Becton Dickinson and Company Cook Group Incorporated Cordis CryoLife Inc. Getinge AB Heat Medical Europe BV LeMaitre Vascular Medtronic plc Terumo Medical Corporation W. L. Gore & Associates Inc. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/gjAgGaYX #VascularGrafts #Surgery #MedicalInnovation #Healthcare #markettrends #researchreport #marketreport #marketforecast #marketgrowth #businessinsights #industryanalysis #marketoutlook #growthprojections #marketstatistics #competitiveanalysis #trendanalysis #marketinsights #imarcgroup

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗗𝗶𝘀𝗽𝗼𝘀𝗮𝗯𝗹𝗲 𝗨𝗿𝗲𝘁𝗲𝗿𝗼𝘀𝗰𝗼𝗽𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Disposable Ureteroscope Market Size, Share & Trends Analysis Report By Product (Flexible Ureteroscopes, Rigid Ureteroscopes), By Application (Urolithiasis, Urethral Stricture, Kidney Cancer, Others), By End-user (Hospitals, Clinics), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028 📚 𝐆𝐞𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐚𝐭 𝐝𝐢𝐬𝐜𝐨𝐮𝐧𝐭𝐞𝐝 𝐩𝐫𝐢𝐜𝐞:👇 https://lnkd.in/dX5TeqAn 📚𝐓𝐨𝐩 𝐌𝐨𝐫𝐞 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐀𝐫𝐞::👇 ADVIN HEALTH CARE Biomerics Boston Scientific CR KENNEDY - Medical Solutions Dornier MedTech E. M. S. Electro Medical Systems España ELMED Medical Systems FUJIFILM Holdings Corporation Hoya KARL STORZ Obex Medical Olympus Corporation PENTAX Medical Prosurg. Pusen Medical Richard Wolf GmbH Rocamed SAM SCHÖLLY FIBEROPTIC GMBH Smith+Nephew. Stryker

Patient Positioning Systems Market Size, Share & Trends Analysis Report By Product (Tables, Surgical Tables, Radiolucent Imaging Tables, Examination Tables, Accessories, Other Patient Positioning Systems) By Application (Surgeries, Disease Diagnosis, Cancer Therapy) By End User (Hospitals, Ambulatory Surgery Centers, Diagnostic Laboratories, Other End Users), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. Check out the latest report from 𝐈𝐧𝐭𝐞𝐥𝐥𝐞𝐜𝐭𝐮𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝟐𝟎𝟐𝟑-𝟐𝟎𝟑𝟏 Covers Various 𝐑𝐞𝐠𝐢𝐨𝐧𝐬 Including: #NorthAmerica #Europe #AsiaPacific #LatinAmerica #Africa. Don't miss out on this opportunity to stay informed about the latest trends in the Industry. 🌐𝐈𝐌𝐈𝐑 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐏𝐯𝐭. 𝐋𝐭𝐝. 𝐆𝐞𝐭 𝐭𝐡𝐞 𝐬𝐚𝐦𝐩𝐥𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: https://lnkd.in/dXh_P3FD 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐰𝐨𝐫𝐤𝐢𝐧𝐠 𝐢𝐧 𝐭𝐡𝐞 𝐦𝐚𝐫𝐤𝐞𝐭: ALVO Medical Anetic Aid Ltd. Beaver Healthcare and Rehabilitation Center Transasia Bio-Medicals Ltd. Bristol Maid - Hospital Metalcraft Ltd CQ Medical Formerly CIVCO Radiotherapy C-RAD AB Dren Bio, Inc. Elekta Eschmann Technologies Ltd FAMED Żywiec Gendron Getinge @Graham-Field (GF Health Products, Inc) Inc. GPC Medical Ltd. Guangdong Meicen Medical Equipment Co., Ltd. Hillrom Innovative Medical Products Leoni Studer Hard AG Mediland Enterprise Corporation Medline Industries, LP Medtronic Merivaara Corp. Mizuho OSI Moore Medical NARANG MEDICAL LIMITED Oncology Systems Limited ONCOTECH Medical Systems OPT SurgiSystems Orfit ProBed Medical SchureMed Skytron Smith+Nephew STERIS Stryker The Brewer-Garrett Company Xodus Medical #positioning #branding #marketing #business #brandpositioning #digitalmarketing #brandstrategy #marketingstrategy #socialmediamarketing #socialmedia #brand #g #starreviews #strategy #design #brandingstrategy #communication #advertising #onlinemarketing #brandidentity #reputation #websitetraffic #remarketing #contentisking #reputationmanagement #retargeting #internetsolutions #reputationmarketing #onlinelocalvideo #reviews

Welcome to May! Happy Friday, and the weekly dive into news and updates across #woundcare, #diabetes, #footandankle and #limbsalvage. 📅 ******************************************* 📈 Financial 📈 MiMedx q1 earnings – Net Sales of $85 Million up 18% vs prior year. Key drivers were an improved capital structure, a distribution agreement with Regenity Biosciences for a particulate xenograft, additions to their B.O.D, and the launch of an online ordering/account management platform. Smith+Nephew Q1 earnings – Overall increase of 2.9%, with Advanced Wound Management seeing a 2% decline vs prior year. This was attributed to a 9.8% drop in Bioactives and directed at the volatility of Santyle due to a strong Q4 disrupting normal flow. Stryker Q1 earnings – Organic sales increase of 10% vs prior year with #trauma and #extremities seeing a 7.9% increase vs prior year. Zimmer Biomet Q1 earnings – Net sales of 3.2% growth vs prior year. SET (Sports Extremities and Trauma) saw a 4.4% increase. Organogenesis Q1 earnings release May 9 Spectral AI Q1 earnings release May 7 Sanara MedTech Q1 earnings release May 13 ******************************************* 📢 News 📢 Xtant Medical announced the launch of two new amniotic membrane allografts, SimpliGraft and SimpliMax, which are intended to treat wounds. These products are made at their facility in Montana and will be marketed through their distribution network. Johns Hopkins Hospital and Healthy.io have partnered to improve chronic wound care with the use of smartphone-based technology, allowing for easier documentation and wound monitoring. Healthy.io's technology allows for seamless collaboration and flexibility and has already seen promising results in clinical adjustments for patients. ******************************************* 🔦 Spotlight on Innovation 🔦 I was able to catch up with Sandeep Gopalakrishnan of Auxillium Health. This is an interesting new company looking to help drive improvements in woundcare through the use of #BigData and #AI. They have a unique solution, in that while they offer a method of image capture/analysis, they also interact with other technologies and devices, full EHR implementation and comprehensive data analytics, a truly hub and spoke approach. ******************************************* If you have or are aware of new companies and advancements in this space, reach out - I'd love to connect and learn about it. If you'll be at #SAWCSpring - give me a shout and let's connect. And that's it for this week, until next time. #chronicwounds #diabetesmanagement #chronicdisease #trauma

Check out the latest report from IMIR Market Research Pvt. Ltd. on the 𝗩𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗚𝗿𝗮𝗳𝘁𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 Outlook and Geography Forecast till 2028 Don't miss out on this opportunity to stay informed about the latest trends in the industry. Vascular Grafts Market Size, Share & Trends Analysis Report Vascular Graft Market by Raw Material (Polyester Grafts, ePTFE, Polyurethane Grafts, Biosynthetic Grafts), Vascular Graft Market by Indication (Endovascular Aneurysm Repair, {Abdominal Aortic Aneurysms Repair, Thoracic Aortic Aneurysm Repair}), Peripheral Vascular, Hemodialysis Access), Vascular Graft Market by End User (Hospitals, Ambulatory Surgical Centers), Global Economy Insights, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2023 - 2031. Global Vascular Grafts Market size was valued at USD 1.7 Billion in 2022 and is projected to reach USD 3.13 Billion by 2031, growing at a CAGR of 7% from 2022 to 2031 according to a new report by Intellectual Market Insights Research. 📚 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗳𝗿𝗲𝗲 𝘀𝗮𝗺𝗽𝗹𝗲 𝗥𝗲𝗽𝗼𝗿𝘁:👇 https://lnkd.in/dFB68rR6 Abbott Laboratories - Lafrancol S.A.S B. Braun Group. Bard Peripheral Vascular, Inc. BD Cardinal Health  Cook Medical Cordis CRYOLIFE company Ltd. Endologix LLC Getinge Maquet Getinge Group Gore Medical Centre SHL Medical LeMaitre  Maquet Getinge Group Medtronic C. R. Bard GmbH Shanghai Suokang Medical Implants Co. Ltd. Terumo Medical Corporation Terumo Aortic Vascular Concepts Limited Vascular Dynamics Vascular Graft Solutions Medtronic Cardiac and Vascular   WL GORE Y ASOCIADOS SL

Sports Medicine Market | Grows at CAGR of 5.7% by 2025 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞-https://lnkd.in/dsWnBA7r The global sports medicine market in terms of revenue was estimated to be worth $5.5 billion in 2020 and is poised to reach $7.2 billion by 2025, growing at a CAGR of 5.7% from 2020 to 2025. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Arthrex Smith+Nephew DePuy Synthes Stryker Breg CONMED Corporation Zimmer Biomet DJO Global Switzerland SARL Mueller Sports Medicine, Inc. Wright Medical Group N.V. RTI Surgical Holdings, Inc Performance Health Bauerfeind AG Medtronic KARL STORZ Össur MedShape, Inc. - acquired by Enovis™ Biotek Ortho

Cardiovascular Devices Market Size And Forecast According to @Verified Market Reports, The Cardiovascular Devices Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024–2030. The #growth of the market can be attributed to the increasing demand for Cardiovascular Devices Market owning to the #Hospitals #Clinics Applications across the global level. The report provides #insights regarding the lucrative opportunities in the #Cardiovascular Devices Market at the country level. The report also includes a precise #cost, #segments, #trends, #region, and #commercial #development of the major key players globally for the projected period. Top Key Player mentioned as:- > Biomerics > MCRA > Semler Scientific® > Orchid Orthopedic Solutions > GMED North America > Innovative Medical Devices, Inc. > Sorin Group > VYGON > Creganna Medical > Terumo Europe > MEDISPEC > Scitech Medical > Lepu Medical Technology (Beijing) Co., Ltd. > Hatch Medical, L.L.C. > Robocath > RW Search > Tecnifar > Aran Biomedical > MedTech Mavens LLC > LifeMed Group > VHC GROUP > Al Umnia Medical > Aran R&D > ÅKRN, Now Part of NAMSA > Global Health Corps > FineHeart > Advant Medical: a UFP Technologies Company > Goodman Medical Ireland Ltd > V-Wave > S3V Vascular Technologies > GRK Medical Devices Pvt. Ltd. > LATINABA > Medical Technology Ireland > Transit Scientific > Veranex Preclinical Services, France (Formerly known as IMMR) > Helix Medical Recruitment Ltd > IKAR > Qualitis SA - now part of Optimapharm Group > Lepu Medical India > Orbees Medical The Cardiovascular Devices Market report has been separated according to separate categories, such as product type, application, end-user, and region. By Type :- • Cardiac Rhythm Management (CRM) Devices • Interventional Cardiology Devices • Defibrillator Devices • Peripheral Vascular Devices • Prosthetic Heart Valve Devices • Others By Application :- • Hospitals • Clinics • Others Get More Info (Report)👉:- https://lnkd.in/gYfsVWyG #data #sales #marketresearch #research #entrepreneur #businessstrategy #technology #data #sales #datacollection #salesfunnel #contentmarketing #bhfyp #size #forecast # #Share #Scope #Opportunities #Analysis

Joint Anatomical Model Market 𝐒𝐢𝐳𝐞 𝐀𝐧𝐝 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 Joint Anatomical Model Market size is expected to develop revenue and exponential market growth at a remarkable CAGR during the forecast period from 2024–2031. The comprehensive report of the Joint Anatomical Model Market will analyse data changes and their impact on the market at the global level. It also analyses the overall growth of companies in the market and their abilities to manage and control profit levels, which is highly important to any investor wishing to open and expand a company within the same market. ➢𝐓𝐨𝐩 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐦𝐞𝐧𝐭𝐢𝐨𝐧𝐞𝐝 𝐚𝐬 𝐛𝐞𝐥𝐨𝐰: ➢ Joint Commission ➢ Joint Commission Laboratory Accreditation ➢ Illinois Bone & Joint Institute ➢ Ambulatory Care Accreditation - The Joint Commission ➢ NYU Hospital for Joint Diseases ➢ Hospital Accreditations & Certifications - The Joint Commission ➢ Home Care Accreditation - The Joint Commission ➢ Behavioral Health Care Accreditation - The Joint Commission ➢ The AANS/CNS Joint Section on Tumors ➢ Joint Medical Holdings ➢ Grand Lake Health System (Joint Township District Memorial Hospital) ➢ Nursing Care Center & Assisted Living Community Accreditation - The Joint Commission ➢ Joint Initiative Council ➢ Traphaco Joint Stock Company ➢ Клиника 21-го Века (Spine&Joint) ➢ Bone and Joint Canada ➢ Wuhan Life Origin Biotech Joint Stock Co Ltd ➢ Joint Commission On Accreditation Of Healthcare Organizations ➢ The Social and Health Care Joint Authority of South Savo ➢ NYU/Hospital for Joint Diseases Orthopaedic Institute ➢ Wuhan Life Origin Biotech Joint Stock Co Ltd ➢ Joint Commission On Accreditation Of Healthcare Organizations ➢ Joint Movement for Bone Health ➢ The Social and Health Care Joint Authority of South Savo ➢ NYU/Hospital for Joint Diseases Orthopaedic Institute ➢ Piramal Pharma Solutions ➢ PCI Pharma Services ➢ LEO Pharma ➢ Aurobindo Pharma USA, Inc. ➢ Aspen Pharma Group ➢ Sumitomo Pharma America, Inc. ➢ EVA pharma ➢ Getz Pharma ➢ Angelini Pharma ➢ Fidia Pharma #data #sales #marketresearch #research #entrepreneur #businessstrategy #technology #data #sales #datacollection #salesfunnel #contentmarketing #bhfyp #size #forecast # #Share #Scope #Opportunities #Analysis #JointAnatomicalModel